AZTherapies, Inc.

AZTherapies, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2011-01-01
Employees
1
Market Cap
-
Website
http://www.aztherapies.com

Randomized I/II Phase Study of ALZT-OP1 Combination Therapy in Alzheimer's Disease and Normal Healthy Volunteers

First Posted Date
2020-09-30
Last Posted Date
2022-03-03
Lead Sponsor
AZTherapies, Inc.
Target Recruit Count
56
Registration Number
NCT04570644
Locations
🇺🇸

Panax Clinical Research, Miami Lakes, Florida, United States

A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease

Phase 2
Terminated
Conditions
Interventions
First Posted Date
2020-06-11
Last Posted Date
2021-11-08
Lead Sponsor
AZTherapies, Inc.
Target Recruit Count
12
Registration Number
NCT04428775
Locations
🇺🇸

Columbia University Medical Center, New York, New York, United States

🇺🇸

Mayo Clinic, Jacksonville, Florida, United States

🇺🇸

UCSD Altman Clinical and Translational Research Institute, La Jolla, California, United States

and more 3 locations

Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease

First Posted Date
2015-09-11
Last Posted Date
2021-11-10
Lead Sponsor
AZTherapies, Inc.
Target Recruit Count
620
Registration Number
NCT02547818
Locations
🇺🇸

Syrentys Clinical Research, Santa Ana, California, United States

🇺🇸

CITrials, Riverside, California, United States

🇺🇸

Parkinson's Disease & Movement Disorders Center of Boca Raton, Boca Raton, Florida, United States

and more 111 locations

Phase 1 Study of ALZT-OP1 Combination Therapy in Normal Healthy Volunteers

First Posted Date
2015-06-26
Last Posted Date
2015-07-21
Lead Sponsor
AZTherapies, Inc.
Target Recruit Count
26
Registration Number
NCT02482324
Locations
🇺🇸

Panax Clinical Research, Miami Lakes, Florida, United States

© Copyright 2024. All Rights Reserved by MedPath